Top View
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION
- REBETOL Safely and Effectively
- Comparative Effectiveness and Safety of Ribavirin Plus Interferon
- Ribavirin Information for Patients
- In Vitro Combination Studies of Tenofovir and Other Nucleoside Analogues with Ribavirin Against HIV-1 Nicolas a Margot and Michael D Miller*
- Impact of Repurposed Drugs on the Symptomatic COVID-19 Patients
- Antiviral Therapeutic Approaches for SARS-Cov-2 Infection: a Systematic Review
- Pegasys, INN-Peginterferon Alfa-2A
- HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use MAVYRET Safely and Effec
- Simeprevir (Olysio ™) UTILIZATION MANAGEMENT CRITERIA
- Pegylated Interferon Alpha 2A
- PEGASYS Prescribing Information
- These Highlights Do Not Include All the Information Needed to Use RIBAVIRIN TABLETS Safely and Effectively
- ZEPATIER Is Recommended
- Ribavirin Teva, INN-Ribavirin
- NDA 21-356/S-011 Page 4 VIREAD (Tenofovir Disoproxil Fumarate)
- Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence
- Pegasys (Peginterferon Alfa-2A) Label
- Perspectives for Antivirals to Limit SARS-Cov-2 Infection (COVID-19)
- (Ombitasvir/Paritaprevir/Ritonavir) & Ribavirin Treatment Agreement
- Harvoni® (Ledipasvir/Sofosbuvir) & Ribavirin Treatment Agreement
- Managing Side Effects of Sofosbuvir and Ribavirin
- New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-Cov-2 Infection
- (Ribavirin, USP) Capsules and INTRON® a (Interferon Alfa-2B, Recombinant) Injection
- An Analytical Study of Drug Utilization, Disease Progression, and Adverse Events Among 165 COVID-19 Patients
- Efficacy and Safety of Simeprevir in Combination with Sofosbuvir, Once-Daily, for Genotype 1 Chronic Hepatitis C
- VIREAD® (Tenofovir
- Real-World Safety and Efficacy of Paritaprevir/Ritonavir/Ombitasvir Plus
- Moderiba™ (Ribavirin, USP) Safely and Effectively
- MEDICATION GUIDE REBETOL® (REB-Eh-Tol) (Ribavirin) Capsules and Oral Solution What Is the Most Important Information I Should Know About REBETOL? 1
- Ribavirin 200 Mg Capsules Cells That Fight Infection, and Blood Clotting Cells Called Ribavirin Platelets)
- SOVALDI (Sofosbuvir) Tablets, for Oral Use Symptomatic Bradycardia May Occur in Patients Taking Initial U.S
- Nucleotide Analogues As Inhibitors of SARS-Cov Polymerase
- Epclusa® (Sofosbuvir/Velpatasvir) & Ribavirin Information Packet
- Ribavirin (Copegus, Rebetol, Ribasphere)
- Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (Teevir)
- (COVID-19)—Lessons Learned from Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) Therapy: a Systematic Review Protocol
- Treatment of Hepatitis C with Pegylated Interferon and Ribavirin, with Or Without Boceprevir Or Telaprevir
- Olysio, INN-Simeprevir
- Guidelines for ATC Classification and DDD Assignment 2021
- Guidelines for ATC Classification and DDD Assignment 2011
- HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use • Neuropsychiatric Events
- Viread, INN-Tenofovir Disoproxil Fumarate
- PEGASYS, PEGINTRON, and RIBAVIRIN Pegasys (Peginterferon
- Viekira Pak (Ombitasvir, Paritaprevir and Ritonavir Tablets Co-Packaged
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Rapid Therapeutic Recommendations in the Context of a Global
- TECHNIVIE (Ombitasvir, Paritaprevir and Ritonavir) Tablets, for Oral Use Initial U.S
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/PBIRG ANATOMICAL CLASSIFICATION
- PEG-INTERFERON Alfa-2B and Ribavirin
- SOVALDI Safely and Effectively
- Incidence of Thyroid Dysfunction During Interferon Alfa-2B and Ribavirin Therapy in Men with Chronic Hepatitis C a Prospective Cohort Study
- Prioritizing Antiviral Drugs Against SARS-Cov-2 by Integrating Viral
- Anti Hepatitis C Viral Drugs Remdesivir and Uprifosbuvir Derivatives Are Better Inhibitors of SARS Cov2 RNA-Dependent RNA Polymerase Determined by Docking Studies
- SYSTEMATIC REVIEW: Drug-Drug Interactions Between Antiretrovirals
- Supplemental Table 1: Inclusion and Exclusion Criteria
- 2011 Pipeline Report Second Edition
- PEGASYS (Peginterferon Alfa-2A), May Cause Or Aggravate Fatal Or Life-Threatening Neuropsychiatric, Autoimmune, Ischemic, and Infectious Disorders
- Evaluation on the Antiviral Activity of Ribavirin Against Infectious
- A Lateral Flow Immunochromato-Graphic Strip Test
- Why Re-Purposing HIV Drugs Lopinavir/Ritonavir to Inhibit the SARS
- ESAC-Net Reporting Protocol 2018.Docx Introduction